Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home

User menu

  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

ASHNR American Society of Functional Neuroradiology ASHNR American Society of Pediatric Neuroradiology ASSR
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds

AJNR Awards, New Junior Editors, and more. Read the latest AJNR updates

Research ArticleBRAIN
Open Access

Proton MR Spectroscopy Improves Discrimination between Tumor and Pseudotumoral Lesion in Solid Brain Masses

C. Majós, C. Aguilera, J. Alonso, M. Julià-Sapé, S. Castañer, J.J. Sánchez, Á. Samitier, A. León, Á. Rovira and C. Arús
American Journal of Neuroradiology March 2009, 30 (3) 544-551; DOI: https://doi.org/10.3174/ajnr.A1392
C. Majós
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. Aguilera
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Alonso
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Julià-Sapé
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Castañer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J.J. Sánchez
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Á. Samitier
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. León
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Á. Rovira
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. Arús
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Fig 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig 1.

    Average spectra of tumors and pseudotumors calculated with the cases included in the training-set. Arrows depict the points that showed significant differences between the 2 groups in the statistical analysis. A, Short TE (TE, 30 ms) spectra showed significant differences at 3.55 ppm (MI). Although differences in the mean spectra can also be seen at 2.02 ppm (NAA) and 3.22 ppm (CHO), no statistical significance was reached. B, Long TE (TE, 136 ms) spectra showed significant differences at 2.02 ppm (NAA), 2.36 and 2.48 ppm (GLX), and 3.22 ppm (CHO).

  • Fig 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig 2.

    Case 81. Anaplastic oligoastrocytoma. A, FLAIR-weighted images show a hyperintense subcortical lesion on the right frontal lobe. B, The lesion shows slight enhancement on T1-weighted images obtained after contrast administration. C, Decrease in the apparent diffusion coefficient (ADC) is seen on the ADC map. The possibility of a cortical infarct was considered. D, 1H-MR spectroscopy at short TE shows slight increase of the mIns/NAA ratio, high CHO, and low NAA. E, 1H-MR spectroscopy at long TE shows high CHO and low NAA levels. F, Graph constructed with the mIns/NAA ratio at short TE (x axis) and CHO/NAA at long TE (y axis) of the universe (latent space) of cases of the training-set projects the case (cross) in the tumoral area. The straight line in the graph depicts the cutting point between tumor and pseudotumor on the basis of the combined ratio value (formula, x + y = 3.33). Values obtained for the classifiers were mIns/NAA ratio at short TE, 1.04 (>0.90, suggesting tumor); CHO/NAA ratio at long TE, 7.52 (>1.90, suggesting tumor), and combined ratio, 8.56 (>3.3, suggesting tumor). The lesion was an anaplastic oligoastrocytoma on the pathologic assessment.

  • Fig 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig 3.

    Case 68. Unspecific benign pseudotumoral mass. A, FLAIR-weighted images show enlargement and hyperintensity of the head of the right caudate nucleus and left thalamus. B, T1-weighted images after contrast administration show slight discontinuous contrast enhancement. C, 1H-MR spectroscopy at short TE. Ratios between CHO, Cr, and NAA are within the normal range. D, 1H-MR spectroscopy at long TE shows no significant anomalies in the ratios between CHO, Cr, and NAA. E, Graph constructed with the mIns/NAA ratio at short TE (x axis) and CHO/NAA ratio at long TE (y axis) of the universe (latent space) of cases of the training-set projects the case (cross) in the nontumoral area. The straight line in the graph depicts the cutting point between tumor and pseudotumor on the basis of the combined ratio value (formula, x + y = 3.33). The arrow highlights the position of the case. Values obtained for the classifiers were mIns/NAA ratio at short TE, 0.48 (<0.90, suggesting nontumor); CHO/NAA ratio at long TE, 0.55 (<1.90, suggesting nontumor); and combined ratio, 1.03 (<3.3, suggesting nontumor). The pathologic assessment of a stereotactic biopsy was “inflammatory changes.” F, Follow-up with axial FLAIR images obtained in 8 months shows complete resolution of previous abnormalities in the images. Note a small hypointense area on the head of the caudate nucleus (arrow) corresponding to the biopsy area.

Tables

  • Figures
    • View popup
    Table 1:

    Follow-up, biopsy findings, and definitive diagnosis of 16 pseudotumoral lesions

    Case No.Follow-up (Months/Evolution of Lesion)Histologic ExaminationFinal Diagnosis
    277 m/Focal atrophyNoAcute arterial infarct
    1326 m/Lesion regression. Detection of new lesions on follow-upYes, brain tissue without abnormalitiesMultiple sclerosis
    1714 m/Lesion regressionNoAcute disseminated encephalomyelitis
    2830 m/Lesion regressionYes, brain tissue without abnormalitiesMultiple sclerosis
    332 m/Lesion regressionNoUnspecific
    3475 m/Lesion regression. Detection of new lesions on follow-upYes, inflammatory, gliosisMultiple sclerosis
    4235 m/Focal atrophyYes, inflammatory, gliosisUnspecific
    5230 m/Lesion regression. Resolution of contrast enhancementYes, inflammatory, gliosisUnspecific
    608 m/Lesion regression. Resolution of contrast enhancementNoMultiple sclerosis
    6227 m/Lesion regressionYes, inflammatoryUnspecific
    6420 m/Lesion regression. Resolution of contrast enhancementNoUnspecific
    688 m/Lesion resolutionYes, inflammatoryUnspecific
    726 m/Lesion regression. Focal atrophyNoAcute arterial infarct
    7811 m/Lesion regressionNoAcute arterial infarct
    804 m/Lesion regressionNoVenous infarct
    828 m/Lesion regressionNoMultiple sclerosis
    • View popup
    Table 2:

    Final diagnoses of the cases included in the study

    DiagnosisNumber of Cases
    TumorsTraining-SetTest-Set
        Low-grade astrocytoma (WHO grade II)194
        Oligodendroglioma (WHO grade II)43
        Oligoastrocytoma (WHO grade II)31
        Anaplastic astrocytoma (WHO grade III)1611
        Anaplastic oligoastrocytoma (WHO grade III)61
    PseudotumorsTraining-SetTest-Set
        Acute infarct13
        Multiple sclerosis32
        Acute disseminated encephalomyelitis10
        No specific diagnosis33
    Total5628
    • View popup
    Table 3:

    Confidence rating of 5 neuroradiologists in the discrimination between tumor and pseudotumor in 28 test-cases, before and after having available spectroscopic information

    Step 1: Evaluation with MR Imaging AloneStep 2: Evaluation with MR Imaging and MR Spectroscopy
    0*1*2*3*4*TOTAL
    0*323109
    1*44413025
    2*02010113
    3*018112747
    4*00014546
    TOTAL79153673140
    • Note:—The numbers in the table represent the number of times that each combination of scores was given by participating neuroradiologists.

    • * Modified scores: 0, quite certainly the wrong diagnosis; 1, probably the wrong diagnosis; 2, equivocal; 3, probably the right diagnosis; and 4, quite certainly the right diagnosis.

PreviousNext
Back to top

In this issue

American Journal of Neuroradiology: 30 (3)
American Journal of Neuroradiology
Vol. 30, Issue 3
March 2009
  • Table of Contents
  • Index by author
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Proton MR Spectroscopy Improves Discrimination between Tumor and Pseudotumoral Lesion in Solid Brain Masses
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Cite this article
C. Majós, C. Aguilera, J. Alonso, M. Julià-Sapé, S. Castañer, J.J. Sánchez, Á. Samitier, A. León, Á. Rovira, C. Arús
Proton MR Spectroscopy Improves Discrimination between Tumor and Pseudotumoral Lesion in Solid Brain Masses
American Journal of Neuroradiology Mar 2009, 30 (3) 544-551; DOI: 10.3174/ajnr.A1392

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
0 Responses
Respond to this article
Share
Bookmark this article
Proton MR Spectroscopy Improves Discrimination between Tumor and Pseudotumoral Lesion in Solid Brain Masses
C. Majós, C. Aguilera, J. Alonso, M. Julià-Sapé, S. Castañer, J.J. Sánchez, Á. Samitier, A. León, Á. Rovira, C. Arús
American Journal of Neuroradiology Mar 2009, 30 (3) 544-551; DOI: 10.3174/ajnr.A1392
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Purchase

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Conclusions
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Diagnostic Accuracy of MR Spectroscopic Imaging and 18F-FET PET for Identifying Glioma: A Biopsy-Controlled Hybrid PET/MRI Study
  • Spatial Relationship of Glioma Volume Derived from 18F-FET PET and Volumetric MR Spectroscopy Imaging: A Hybrid PET/MRI Study
  • Utility of Proton MR Spectroscopy for Differentiating Typical and Atypical Primary Central Nervous System Lymphomas from Tumefactive Demyelinating Lesions
  • MR Imaging of Neoplastic Central Nervous System Lesions: Review and Recommendations for Current Practice
  • Proton MR Spectroscopy Provides Relevant Prognostic Information in High-Grade Astrocytomas
  • Intracranial dural arteriovenous fistula presenting as an enhancing lesion of the medulla
  • Crossref (80)
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Imaging of Brain Tumors: MR Spectroscopy and Metabolic Imaging
    Alena Horská, Peter B. Barker
    Neuroimaging Clinics of North America 2010 20 3
  • Glioma imaging in Europe: A survey of 220 centres and recommendations for best clinical practice
    S. C. Thust, S. Heiland, A. Falini, H. R. Jäger, A. D. Waldman, P. C. Sundgren, C. Godi, V. K. Katsaros, A. Ramos, N. Bargallo, M. W. Vernooij, T. Yousry, M. Bendszus, M. Smits
    European Radiology 2018 28 8
  • Brain Proton Magnetic Resonance Spectroscopy
    Débora Bertholdo, Arvemas Watcharakorn, Mauricio Castillo
    Neuroimaging Clinics of North America 2013 23 3
  • MR Imaging of Neoplastic Central Nervous System Lesions: Review and Recommendations for Current Practice
    M. Essig, N. Anzalone, S.E. Combs, A. Dörfler, S.-K. Lee, P. Picozzi, À. Rovira, M. Weller, M. Law
    American Journal of Neuroradiology 2012 33 5
  • Magnetic resonance spectroscopic detection of lactate is predictive of a poor prognosis in patients with diffuse intrinsic pontine glioma
    F. Yamasaki, K. Kurisu, Y. Kajiwara, Y. Watanabe, T. Takayasu, Y. Akiyama, T. Saito, R. Hanaya, K. Sugiyama
    Neuro-Oncology 2011 13 7
  • Utility of Proton MR Spectroscopy for Differentiating Typical and Atypical Primary Central Nervous System Lymphomas from Tumefactive Demyelinating Lesions
    S.- S. Lu, S. J. Kim, H. S. Kim, C. G. Choi, Y.- M. Lim, E. J. Kim, D. Y. Kim, S. H. Cho
    American Journal of Neuroradiology 2014 35 2
  • Detection of pseudo brain tumors via stacked LSTM neural networks using MR spectroscopy signals
    Emre Dandıl, Semih Karaca
    Biocybernetics and Biomedical Engineering 2021 41 1
  • Brain Tumors
    Lara A. Brandão, Mark S. Shiroishi, Meng Law
    Magnetic Resonance Imaging Clinics of North America 2013 21 2
  • The INTERPRET Decision-Support System version 3.0 for evaluation of Magnetic Resonance Spectroscopy data from human brain tumours and other abnormal brain masses
    Alexander Pérez-Ruiz, Margarida Julià-Sapé, Guillem Mercadal, Iván Olier, Carles Majós, Carles Arús
    BMC Bioinformatics 2010 11 1
  • Adult Brain Tumors
    Lara A. Brandão, Mauricio Castillo
    Magnetic Resonance Imaging Clinics of North America 2016 24 4

More in this TOC Section

  • Multimodal CT Provides Improved Performance for Lacunar Infarct Detection
  • Optimal MRI Sequence for Identifying Occlusion Location in Acute Stroke: Which Value of Time-Resolved Contrast-Enhanced MRA?
  • Evaluating the Effects of White Matter Multiple Sclerosis Lesions on the Volume Estimation of 6 Brain Tissue Segmentation Methods
Show more BRAIN

Similar Articles

Advertisement

Indexed Content

  • Current Issue
  • Accepted Manuscripts
  • Article Preview
  • Past Issues
  • Editorials
  • Editor's Choice
  • Fellows' Journal Club
  • Letters to the Editor
  • Video Articles

Cases

  • Case Collection
  • Archive - Case of the Week
  • Archive - Case of the Month
  • Archive - Classic Case

More from AJNR

  • Trainee Corner
  • Imaging Protocols
  • MRI Safety Corner
  • Book Reviews

Multimedia

  • AJNR Podcasts
  • AJNR Scantastics

Resources

  • Turnaround Time
  • Submit a Manuscript
  • Submit a Video Article
  • Submit an eLetter to the Editor/Response
  • Manuscript Submission Guidelines
  • Statistical Tips
  • Fast Publishing of Accepted Manuscripts
  • Graphical Abstract Preparation
  • Imaging Protocol Submission
  • Evidence-Based Medicine Level Guide
  • Publishing Checklists
  • Author Policies
  • Become a Reviewer/Academy of Reviewers
  • News and Updates

About Us

  • About AJNR
  • Editorial Board
  • Editorial Board Alumni
  • Alerts
  • Permissions
  • Not an AJNR Subscriber? Join Now
  • Advertise with Us
  • Librarian Resources
  • Feedback
  • Terms and Conditions
  • AJNR Editorial Board Alumni

American Society of Neuroradiology

  • Not an ASNR Member? Join Now

© 2025 by the American Society of Neuroradiology All rights, including for text and data mining, AI training, and similar technologies, are reserved.
Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire